Lance Alstodt

Insider Reports History

Reporting-owner location: Melville, NY
Latest reporting-owner signature: /s/ Lance Alstodt
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Lance Alstodt

Form 4 holding President, CEO, COB, Director, 10%+ Owner

BioRestorative Therapies, Inc.

Security class: Common Stock
Shares / value: 187,497
Estimated value: $299,995
Report date: 06 Oct 2025
Price: $1.60
Ownership: Direct

Form 4 holding President, CEO, COB, Director, 10%+ Owner

BioRestorative Therapies, Inc.

Security class: Stock Option
Shares / value: 791,885
Estimated value
Report date: 06 Oct 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding President, CEO, COB, Director, 10%+ Owner

BioRestorative Therapies, Inc.

Security class: Warrant
Shares / value: 11,719
Estimated value
Report date: 06 Oct 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Lance Alstodt

4 BRTX

BioRestorative Therapies, Inc.

Report period: 06 Oct 2025
Transactions: 2
Transaction value: +$25,000
Accepted by SEC: 20 Oct 2025, 08:02
Role: President, CEO, COB, Director, 10%+ Owner
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 14 Feb 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 19 Feb 2025, 16:22
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 18 Mar 2024
Transactions: 1
Transaction value: -$24,510
Accepted by SEC: 20 Mar 2024, 16:36
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 13 Feb 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Feb 2024, 16:11
Role: President, CEO, COB, Director, 10%+ Owner
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 15 Sep 2023
Transactions: 1
Transaction value: +$3,740
Accepted by SEC: 18 Sep 2023, 09:17
Role: President, CEO, COB, Director, 10%+ Owner
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 13 Sep 2023
Transactions: 1
Transaction value: +$1,226
Accepted by SEC: 13 Sep 2023, 17:00
Role: President, CEO, COB, Director, 10%+ Owner
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 06 Sep 2023
Transactions: 1
Transaction value: +$5,659
Accepted by SEC: 06 Sep 2023, 17:53
Role: President, CEO, COB, Director, 10%+ Owner
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 25 Jul 2023
Transactions: 1
Transaction value: +$10,248
Accepted by SEC: 25 Jul 2023, 17:56
Role: President, CEO, COB, Director, 10%+ Owner
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 20 Mar 2023
Transactions: 1
Transaction value: -$19,649
Accepted by SEC: 22 Mar 2023, 16:47
Role: President, CEO, COB, Director, 10%+ Owner
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 18 Feb 2023
Transactions: 1
Transaction value: -$1,118
Accepted by SEC: 27 Feb 2023, 16:17
Role: President, CEO, COB, Director, 10%+ Owner
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 17 Feb 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 17 Feb 2023, 16:27
Role: President, CEO, COB, Director, 10%+ Owner
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 01 Feb 2023
Transactions: 1
Transaction value: +$1,241
Accepted by SEC: 02 Feb 2023, 13:49
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 27 Jan 2023
Transactions: 1
Transaction value: +$602
Accepted by SEC: 30 Jan 2023, 08:33
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 20 Jan 2023
Transactions: 2
Transaction value: +$627
Accepted by SEC: 24 Jan 2023, 11:27
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 18 Jan 2023
Transactions: 3
Transaction value: +$1,244
Accepted by SEC: 20 Jan 2023, 07:19
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 09 Jan 2023
Transactions: 1
Transaction value: +$308
Accepted by SEC: 10 Jan 2023, 17:06
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 23 Dec 2022
Transactions: 2
Transaction value: +$903
Accepted by SEC: 28 Dec 2022, 07:22
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 07 Dec 2022
Transactions: 1
Transaction value: +$5,375
Accepted by SEC: 07 Dec 2022, 17:04
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 18 Nov 2022
Transactions: 1
Transaction value: +$2,876
Accepted by SEC: 21 Nov 2022, 06:49
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 03 Nov 2022
Transactions: 4
Transaction value: $0
Accepted by SEC: 04 Nov 2022, 16:16
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 22 Sep 2022
Transactions: 2
Transaction value: +$584
Accepted by SEC: 23 Sep 2022, 09:55
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 12 Jul 2022
Transactions: 1
Transaction value: +$2,065
Accepted by SEC: 13 Jul 2022, 08:25
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 30 Jun 2022
Transactions: 1
Transaction value: +$3,408
Accepted by SEC: 01 Jul 2022, 09:20
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 16 Jun 2022
Transactions: 1
Transaction value: +$2,238
Accepted by SEC: 17 Jun 2022, 16:02
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 15 Jun 2022
Transactions: 1
Transaction value: +$2,578
Accepted by SEC: 15 Jun 2022, 17:30
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 14 Jun 2022
Transactions: 1
Transaction value: +$1,956
Accepted by SEC: 15 Jun 2022, 11:01
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 13 Jun 2022
Transactions: 2
Transaction value: +$790
Accepted by SEC: 14 Jun 2022, 11:55
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 08 Jun 2022
Transactions: 1
Transaction value: +$428
Accepted by SEC: 09 Jun 2022, 11:41
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 01 Jun 2022
Transactions: 1
Transaction value: +$920
Accepted by SEC: 03 Jun 2022, 06:58
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 26 May 2022
Transactions: 1
Transaction value: +$9,494
Accepted by SEC: 27 May 2022, 10:23
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 02 May 2022
Transactions: 2
Transaction value: +$1,579
Accepted by SEC: 02 May 2022, 17:14
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 18 Mar 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 Mar 2022, 17:08
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 24 Jan 2022
Transactions: 1
Transaction value: +$4,998
Accepted by SEC: 24 Jan 2022, 16:03
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 05 Jan 2022
Transactions: 1
Transaction value: +$7,700
Accepted by SEC: 05 Jan 2022, 15:52
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 01 Dec 2021
Transactions: 1
Transaction value: +$4,394
Accepted by SEC: 02 Dec 2021, 09:00
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 23 Nov 2021
Transactions: 1
Transaction value: +$15,000
Accepted by SEC: 23 Nov 2021, 16:15
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 22 Nov 2021
Transactions: 1
Transaction value: +$2,499
Accepted by SEC: 22 Nov 2021, 16:29
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 16 Nov 2021
Transactions: 4
Transaction value: +$30,201
Accepted by SEC: 16 Nov 2021, 17:07
Role: President, CEO, COB, Director
Next action: Open filing details

4 BRTX

BioRestorative Therapies, Inc.

Report period: 04 Nov 2021
Transactions: 3
Transaction value: $0
Accepted by SEC: 08 Nov 2021, 16:30
Role: President, CEO, COB, Director
Next action: Open filing details

Insider Reports History

Continue from this owner filing history

Reported holdings for Lance Alstodt

Insider Reports Filed by Lance Alstodt